Faculty Disclosures
| Lauren Schaff, MD, FAAN |
Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG, plc. The institution of Dr. Schaff has received research support from BTG, plc. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Ono. |
| Justin T. Jordan, MD, MPH, FAAN |
Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care. |
| L. Nicolas Gonzalez Castro, MD, PhD |
Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Gonzalez Castro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishing. Dr. Gonzalez Castro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ Best Practice. Dr. Gonzalez Castro has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. An immediate family member of Dr. Gonzalez Castro has or had stock in Takeda. The institution of Dr. Gonzalez Castro has received research support from Merck & Co. |
| Habib E. Akouri |
Mr. Akouri has nothing to disclose. |
| M Salim S. Siddiqui, MD, PhD |
Dr. Siddiqui has nothing to disclose. |
| Alejandro Torres-Trejo, MD |
Dr. Torres-Trejo has nothing to disclose. |
| Khalid M. Salem, MD, PhD |
Mr. Salem has nothing to disclose. |
| Theresa A. Dettling, BSN, JD, MPH, MS |
Ms. Dettling has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Ms. Dettling has stock in Alexion, AstraZeneca Rare Disease. |
| David M. Peereboom, MD |
Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anheart. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeOnc. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orbus. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Peereboom has received research support from Nuvation. The institution of Dr. Peereboom has received research support from Anheart. The institution of Dr. Peereboom has received research support from Pfizer. The institution of Dr. Peereboom has received research support from NeOnc. The institution of Dr. Peereboom has received research support from Bristol-Myers Squibb. The institution of Dr. Peereboom has received research support from Genentech/Roche. The institution of Dr. Peereboom has received research support from Orbus. The institution of Dr. Peereboom has received research support from GCAR. |
| Mira M. Shah, MD |
Ms. Shah has nothing to disclose. |
| sophia lee, MD |
Dr. lee has nothing to disclose. |
| Glen H. Stevens, DO, PhD, FAAN |
The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute. |
| Gail Doughton, PhD |
Dr. Doughton has received personal compensation for serving as an employee of AstraZeneca. An immediate family member of Dr. Doughton has received personal compensation for serving as an employee of AstraZeneca. Dr. Doughton has stock in AstraZeneca. An immediate family member of Dr. Doughton has stock in AstraZeneca. |
| Robert G. Wilson, DO |
Dr. Wilson has nothing to disclose. |
| Shahbaz KHAN, MD |
Dr. KHAN has nothing to disclose. |
| Ignacio Blanco, MD, PhD |
Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks. The institution of Dr. Blanco has received research support from Asociació Catalana Neurofibromatosis (AcNefi). The institution of Dr. Blanco has received research support from Spanish Health Ministry. |
| Susan Sotardi, MD |
Dr. Sotardi has nothing to disclose. |
| Emma Siddiqui |
Ms. Siddiqui has nothing to disclose. |
| Yoomin Lee, Medical Student |
Miss Lee has nothing to disclose. |
| Michael Fisher, MD |
Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks. The institution of Dr. Fisher has received research support from AstraZeneca/Alexion. The institution of Dr. Fisher has received research support from Array BioPharma. |
| Angela M. Mastronuzzi, MD, PhD |
Dr. Mastronuzzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. |
| Vaishnavi Sharma, MBBS |
Dr. Sharma has nothing to disclose. |
| Gareth Ball, PhD |
Dr. Ball has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Ball has received research support from NHMRC. |
| Alyssa Bowling, PharmD |
Ms. Bowling has received personal compensation for serving as an employee of AstraZeneca Rare Disease. Ms. Bowling has stock in AstraZeneca Rare Disease. |
| Shreya Louis, MD, MS |
Dr. Louis has nothing to disclose. |
| Rodrigo Muscogliati, MBBS |
Dr. Muscogliati has nothing to disclose. |
| Seema Nagpal, MD, FAAN |
Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Daiichi-Sankyo. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Enclear. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Plus Therapuetics/Biocept. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. |
| Said C. Farschtschi, MD |
Dr. Farschtschi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharma. Dr. Farschtschi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SpringWorks Therapeutics. The institution of Dr. Farschtschi has received research support from Bundesverband Neurofibromatose Germany. The institution of Dr. Farschtschi has received research support from Nothing is Forever e.V. Germany. |
| Arastoo Vossough, MD |
Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care. |
| James Snyder, DO |
The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Premier Applied Sciences. The institution of Dr. Snyder has received research support from Vizilitics inc. |
| Lamis Yehia, PhD |
Dr. Yehia has nothing to disclose. |
| Angela Swampillai, MBBS, BSc, MRCP, FRCR |
Dr. Swampillai has received personal compensation in the range of $0-$499 for serving as a market research with Adivo Associates. |
| Anika Khandekar |
Ms. Khandekar has nothing to disclose. |
| Aaron F. Alexander-Bloch, MD, PhD |
Mr. Alexander-Bloch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Mr. Alexander-Bloch has stock in Centile Bioscience. The institution of Mr. Alexander-Bloch has received research support from NIH. The institution of Mr. Alexander-Bloch has received research support from DOD. Mr. Alexander-Bloch has received intellectual property interests from a discovery or technology relating to health care. Mr. Alexander-Bloch has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH. |
| Benjamin Movsas, MD |
Dr. Movsas has stock in abbvie. Dr. Movsas has stock in united therapeutics. Dr. Movsas has stock in biolife. Dr. Movsas has stock in acrivon. Dr. Movsas has stock in metlife. The institution of Dr. Movsas has received research support from Siemens. Dr. Movsas has received intellectual property interests from a discovery or technology relating to health care. |
| Ayan S. Mandal, PhD |
Dr. Mandal has nothing to disclose. |
| George Nageeb, MD |
Mr. Nageeb has nothing to disclose. |
| Genevieve Lyons, MSc |
Mrs. Lyons has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. |
| Remo M. Williams |
Mr. Williams has nothing to disclose. |
| Weifeng Song, MD, PhD |
Dr. Song has nothing to disclose. |
| Carolina Barnett Tapia, MD |
Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care. |
| Viveknarayanan Padmanabhan |
Mr. Padmanabhan has nothing to disclose. |
| Ayo Adeyemi, PhD |
Dr. Adeyemi has received personal compensation for serving as an employee of Alexion. Dr. Adeyemi has or had stock in Alexion. |
| Hans H. Shuhaiber, MD |
The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION . |
| Cordula Matthies, MD, PhD |
Prof. Matthies has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Prof. Matthies has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion/ Astra Zeneca. Prof. Matthies has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Prof. Matthies has received research support from German Research Council. |
| Mike Sicilia |
Mr. Sicilia has received personal compensation for serving as an employee of Forian, Inc. |
| Adam M. Robin, MD |
Dr. Robin has nothing to disclose. |
| Kathryn North, MD, MBBS, FRACP |
Dr. North has nothing to disclose. |
| Mark G. Malkin, MD, FAAN |
Dr. Malkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Malkin has received publishing royalties from a publication relating to health care. |
| Jakob Seidlitz, PhD |
Dr. Seidlitz has stock in Centile Bioscience. |
| Andrew Dhawan, MD |
Dr. Dhawan has nothing to disclose. |
| You-Rim Lee, PhD |
The institution of Dr. Lee has received research support from National Institute on Aging (NIA). |
| Ashwin Anand, MPH |
Mr. Anand has nothing to disclose. |
| Milo Writer |
Mr. Writer has nothing to disclose. |
| Nils Muhlert, PhD |
Dr. Muhlert has nothing to disclose. |
| Vinai Gondi |
No disclosure on file
|
| Marica Eoli, MD |
Dr. Eoli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
| Osaama H. Khan |
No disclosure on file
|
| Mina Lobbous, MD |
Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Pharmaceuticals . Dr. Lobbous has received publishing royalties from a publication relating to health care. |
| David Rogawski, MD |
Dr. Rogawski has nothing to disclose. |
| Ying Ni, PhD |
Dr. Ni has nothing to disclose. |
| Nayef Kiame |
Mr. Kiame has nothing to disclose. |
| Stephen L. Brown, PhD |
Prof. Brown has nothing to disclose. |
| Julia Meade, MD |
Dr. Meade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Meade has received personal compensation in the range of $0-$499 for serving as a Consultant for Adivo Associates. |
| Ruju Talati |
Miss Talati has nothing to disclose. |
| Matthew Buczek |
Mr. Buczek has nothing to disclose. |
| Randolph de la Rosa Rodriguez, MD |
Dr. de la Rosa Rodriguez has received personal compensation for serving as an employee of Alexion. Dr. de la Rosa Rodriguez has stock in Astrazeneca. |
| Jonathan Payne, DPsych |
Prof. Payne has nothing to disclose. |
| silverio perrotta, MD |
Prof. perrotta has nothing to disclose. |
| Shruti Garg, MD, PhD |
The institution of Dr. Garg has received research support from US Department of Defence. |
| Alyssa Lucas, MD |
Dr. Lucas has nothing to disclose. |
| Ryan Rilinger |
Mr. Rilinger has nothing to disclose. |
| Tobias Walbert, MD, PhD, FAAN |
Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . |
| Shyam Nyati, PhD |
Dr. Nyati has nothing to disclose. |
| Elie Najjar, MD |
Mr. Najjar has nothing to disclose. |